Icon

AZEDRA (nda209607)- (15mCi/ML)

IOBENGUANE I-131 PROGENICS PHARMS INC
15mCi/ML
No No
Expired Expired
None 2021-Jul-30
None No
AZEDRA is a radioactive therapeutic agent indicated for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
15mCi/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.